- Report
- January 2026
- 181 Pages
Global
From €3144EUR$3,545USD£2,739GBP
€3493EUR$3,939USD£3,043GBP
- Report
- January 2026
- 188 Pages
Global
From €3144EUR$3,545USD£2,739GBP
€3493EUR$3,939USD£3,043GBP
- Report
- April 2026
- 177 Pages
Global
From €5188EUR$5,850USD£4,520GBP
- Report
- April 2026
- 194 Pages
Global
From €5188EUR$5,850USD£4,520GBP
- Report
- February 2026
- 250 Pages
Global
From €3982EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €3982EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €3982EUR$4,490USD£3,469GBP
- Report
- February 2026
- 200 Pages
Global
From €7085EUR$7,990USD£6,173GBP
- Report
- January 2026
- 185 Pages
Global
From €3990EUR$4,500USD£3,477GBP
- Report
- November 2025
- 185 Pages
Global
From €3990EUR$4,500USD£3,477GBP
- Report
- May 2025
- 196 Pages
Global
From €4212EUR$4,750USD£3,670GBP
- Report
- August 2025
- 136 Pages
Global
From €3546EUR$3,999USD£3,090GBP
- Report
- October 2025
- 160 Pages
Global
From €2977EUR$3,358USD£2,594GBP
€3503EUR$3,950USD£3,052GBP
- Report
- October 2025
- 100 Pages
United States
From €5276EUR$5,950USD£4,597GBP
- Report
- July 2025
- 82 Pages
United States
From €3104EUR$3,500USD£2,704GBP
- Report
- May 2025
- 120 Pages
Global
From €5276EUR$5,950USD£4,597GBP
- Report
- August 2025
- 183 Pages
Global
From €3144EUR$3,545USD£2,739GBP
€3493EUR$3,939USD£3,043GBP
- Report
- August 2025
- 184 Pages
Global
From €3144EUR$3,545USD£2,739GBP
€3493EUR$3,939USD£3,043GBP
- Report
- February 2026
- 250 Pages
Global
From €3982EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €3982EUR$4,490USD£3,469GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more